Rosiglitazone (BRL 49653) is an orally active selective PPARgamma agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 µM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].
Molecular Weight:
357.43
Purity:
99.94
CAS Number:
[122320-73-4]
Formula:
C18H19N3O3S
Target:
Apoptosis,Autophagy,Ferroptosis,PPAR,TRP Channel
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
